Raphael Erez's Form 4 filing
DarioHealth Corp. (DRIO) · filed Aug 23, 2024
- Accession no.
- 0001104659-24-092417
- Filed
- Aug 23, 2024
- Trade date
- Aug 20-21, 2024
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $9.40K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Raphael ErezCIK 0001668046 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2024 | Common Stock | PPurchaseAcquired | +5,000 | $0.93 | +$4,650 | 1,927,059 | Direct | |
| Aug 21, 2024 | Common Stock | PPurchaseAcquired | +5,000 | $0.95 | +$4,750 | 1,932,059 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.